Published in Cancer Res on July 15, 1998
Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med (2009) 10.01
Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology (2008) 5.19
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol (2011) 3.15
DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol (1999) 2.78
Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc Natl Acad Sci U S A (2001) 2.55
The molecular genetics of Marfan syndrome and related disorders. J Med Genet (2006) 2.45
Colorectal cancer molecular biology moves into clinical practice. Gut (2010) 2.32
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00
Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol (1999) 1.98
Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut (2000) 1.95
A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc Natl Acad Sci U S A (2003) 1.84
DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut (2000) 1.58
Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol (2000) 1.56
Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci U S A (2000) 1.55
TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology (2009) 1.50
Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J Physiol Gastrointest Liver Physiol (2006) 1.45
BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am J Pathol (1999) 1.36
Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology (2014) 1.32
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis. Nat Med (2011) 1.23
Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer (2006) 1.22
Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. Am J Respir Crit Care Med (2005) 1.22
Targeting TGF-β signaling in cancer. Expert Opin Ther Targets (2013) 1.16
Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut (1999) 1.13
Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol Cell Biol (2005) 1.08
Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair. PLoS One (2008) 1.08
Tgf-beta signaling pathway in lung adenocarcinoma invasion. J Thorac Oncol (2010) 1.07
The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Int J Cancer (2008) 1.06
Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene (2013) 1.04
Murine models of colorectal cancer. Mamm Genome (2009) 1.03
Effects of activin and TGFβ on p21 in colon cancer. PLoS One (2012) 1.01
Chemotherapeutic implications in microsatellite unstable colorectal cancer. Cancer Biomark (2006) 1.01
Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. Mol Carcinog (2010) 1.00
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy. Biomol Ther (Seoul) (2013) 0.99
BMP suppresses PTEN expression via RAS/ERK signaling. Cancer Biol Ther (2007) 0.99
RET is a potential tumor suppressor gene in colorectal cancer. Oncogene (2012) 0.98
Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway. Neoplasia (2006) 0.98
GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers. PLoS One (2014) 0.97
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Am J Pathol (1999) 0.96
Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability. BMC Cancer (2008) 0.95
The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis (2006) 0.94
Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability. BMC Cancer (2010) 0.93
Noninvasive detection of inflammation-associated colon cancer in a mouse model. Neoplasia (2010) 0.91
Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms. PLoS One (2009) 0.89
Iro/IRX transcription factors negatively regulate Dpp/TGF-β pathway activity during intestinal tumorigenesis. EMBO Rep (2014) 0.85
Blockade of Autocrine TGF-β Signaling Inhibits Stem Cell Phenotype, Survival, and Metastasis of Murine Breast Cancer Cells. J Stem Cell Res Ther (2012) 0.84
Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis. Cancer Prev Res (Phila) (2010) 0.83
Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol (2013) 0.83
The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy. Gastrointest Endosc Clin N Am (2008) 0.82
A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum Genet (2004) 0.80
Relationship between grade of microsatellite instability and target genes of mismatch repair pathways in sporadic colorectal carcinoma. Dig Dis Sci (2001) 0.78
Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer. Gastroenterology (2016) 0.77
Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation. PLoS One (2016) 0.77
The genomics of colorectal cancer: state of the art. Curr Genomics (2008) 0.76
Does mutation of transforming growth factor-beta type II receptor gene play an important role in colorectal polyps? Dig Dis Sci (1999) 0.76
Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells. Int J Oncol (2011) 0.75
Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116. Br J Cancer (2000) 0.75
Transposon mutagenesis identifies candidate genes that cooperate with loss of Transforming Growth Factor-beta signaling in mouse intestinal neoplasms. Int J Cancer (2016) 0.75
TGF-β signaling in liver and gastrointestinal cancers. Cancer Lett (2016) 0.75
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system. Breast Cancer Res (2000) 0.75
The effect of CT26 tumor-derived TGF-β on the balance of tumor growth and immunity. Immunol Lett (2017) 0.75
[Clinical, pathological and molecular prognostic factors in colorectal carcinomas]. Pathologe (2003) 0.75
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (1990) 11.18
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst (1991) 3.40
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Conversion of diploidy to haploidy. Nature (2000) 3.28
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Mutations of GTBP in genetically unstable cells. Science (1995) 3.23
Deletion of p16 and p15 genes in brain tumors. Cancer Res (1994) 3.03
Migration and stopover in a small pelagic seabird, the Manx shearwater Puffinus puffinus: insights from machine learning. Proc Biol Sci (2009) 3.03
Essential tremor is not dependent upon cerebellar Purkinje cell loss. Parkinsonism Relat Disord (2012) 2.76
High-resolution endoscopic imaging of the GI tract using optical coherence tomography. Gastrointest Endosc (2000) 2.53
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis (2007) 2.29
Accuracy of clinical diagnosis in parkinsonism--a prospective study. Can J Neurol Sci (1991) 2.26
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet (2000) 2.15
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem (1995) 2.15
Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry (1996) 2.05
Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut (2001) 2.05
22q13 deletion syndrome. Am J Med Genet (2001) 1.94
Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc (2000) 1.83
Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ (2006) 1.83
Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res (1994) 1.82
Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results. Stroke (2002) 1.80
Cerebellar Purkinje cell loss is not pathognomonic of essential tremor. Parkinsonism Relat Disord (2011) 1.73
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology (2007) 1.68
E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat (1999) 1.65
Assessing for audit. Br J Gen Pract (1997) 1.59
Course in Parkinson disease subtypes: A 39-year clinicopathologic study. Neurology (2009) 1.59
Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut (2002) 1.57
Frozen section consultation. Utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol (1995) 1.54
Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol (1988) 1.54
Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature (1978) 1.52
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol (2009) 1.49
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1996) 1.49
Corepressor-induced organization and assembly of the biotin repressor: a model for allosteric activation of a transcriptional regulator. Proc Natl Acad Sci U S A (2001) 1.49
Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res (2001) 1.49
Brain cytochrome oxidase in Alzheimer's disease. J Neurochem (1992) 1.48
Polymerase delta variants in RER colorectal tumours. Nat Genet (1995) 1.47
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res (1996) 1.47
Design of antineoplastic agents on the basis of the "2-phenylnaphthalene-type" structural pattern. 2. Synthesis and biological activity studies of benzo]b]naphtho[2,3-d]furan-6,11-dione derivatives. J Med Chem (1993) 1.41
Case-control studies of sporadic cryptosporidiosis in Melbourne and Adelaide, Australia. Epidemiol Infect (2002) 1.35
Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun (1991) 1.34
Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology (1996) 1.30
Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech (2009) 1.25
Investigations into sources of lead in the environment of urban children. Environ Res (1975) 1.24
Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada. Epilepsia (1995) 1.23
Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology (2008) 1.22
Competing protein:protein interactions are proposed to control the biological switch of the E coli biotin repressor. Protein Sci (2001) 1.21
Characteristics of patients with community-acquired pneumococcal pneumonia. Med J Aust (1999) 1.21
MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology (2011) 1.19
High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results. Gastrointest Endosc (1998) 1.18
Current magnitude of occupational disease in the United States. Estimates from New York State. Ann N Y Acad Sci (1989) 1.18
Research into fabrics used in compression therapy and assessment of their impact on treatment regimens. J Wound Care (2014) 1.16
Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma. Am J Surg Pathol (1999) 1.14
Lung cancer and occupation: results of a multicentre case-control study. Br J Ind Med (1992) 1.13
Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J Neurochem (1992) 1.13
A randomised controlled trial of a double layer of Allevyn compared to Jellonet and proflavin as a tie-over dressing for small skin grafts. J Plast Reconstr Aesthet Surg (2007) 1.09
Turning On uracil-DNA glycosylase using a pyrene nucleotide switch. J Biol Chem (2001) 1.07
Clinicopathologic observations in essential tremor: report of six cases. Neurology (1991) 1.05
Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia (1994) 1.04
Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis. Antimicrob Agents Chemother (1986) 1.04
High-resolution endoscopic imaging of the GI tract: a comparative study of optical coherence tomography versus high-frequency catheter probe EUS. Gastrointest Endosc (2001) 1.04
Amplification of cyclin genes in colorectal carcinomas. Cancer Res (1993) 1.04
Beneficial effect of microsurgical varicocelectomy on human sperm DNA integrity. Hum Reprod (2004) 1.03
Malignant pleural mesothelioma presenting as spontaneous pneumothorax: a case series and review. Am J Ind Med (2000) 1.03
Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol (1990) 1.02
The value of the Nile Blue sulphate stain in the cytology of the liquor amnii. J Obstet Gynaecol Br Commonw (1969) 1.02
Recruitment of patients into an internet-based clinical trials database: the experience of OncoLink and the National Colorectal Cancer Research Alliance. J Clin Oncol (2004) 1.01
Kimura's disease. Indian J Otolaryngol Head Neck Surg (2004) 1.01
Simulation-based inexact chance-constrained nonlinear programming for eutrophication management in the Xiangxi Bay of Three Gorges Reservoir. J Environ Manage (2012) 1.00
The impact of maternal alcohol and illicit drug use on children's behavior problems: evidence from the children of the national longitudinal survey of youth. J Health Econ (2001) 1.00
Simple scale for assessing level of dependency of patients in general practice. Br Med J (Clin Res Ed) (1986) 0.99
Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay. Mod Pathol (1992) 0.98
Pertussis toxin export genes are regulated by the ptx promoter and may be required for efficient translation of ptx mRNA in Bordetella pertussis. Infect Immun (1995) 0.98
Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res (1995) 0.98
Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Res (1994) 0.97
Effect of bronchoscopy with premedication and topical anesthesia on arterial blood gases. Arch Surg (1968) 0.97
Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res (1995) 0.95
The offset of morphine tolerance in rats and mice. Br J Pharmacol (1975) 0.95
CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort. Autoimmunity (2002) 0.95
The carboxyl-terminal domain of human erythrocyte band 3. Description, isolation, and location in the bilayer. J Biol Chem (1981) 0.94
Human papillomavirus infection related to oesophageal carcinoma in black South Africans. A preliminary study. S Afr Med J (1986) 0.93
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology (1996) 0.93
Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Res (2001) 0.93
A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol (2000) 0.92
The influence of inhibitory afferents on the development of postsynaptic dendritic arbors. J Comp Neurol (1992) 0.92
Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol (1990) 0.91
Fine needle aspiration in breast lumps. Ulster Med J (1982) 0.91
Reevaluating the carcinogenicity of ortho-toluidine: a new conclusion and its implications. Regul Toxicol Pharmacol (1992) 0.90
Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair. Cell Death Dis (2012) 0.90
A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. J Clin Invest (1994) 0.89